Coumarin: A natural, privileged and versatile scaffold for bioactive compounds

A Stefanachi, F Leonetti, L Pisani, M Catto, A Carotti - Molecules, 2018 - mdpi.com
Many naturally occurring substances, traditionally used in popular medicines around the
world, contain the coumarin moiety. Coumarin represents a privileged scaffold for medicinal …

Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …

MG Savelieff, G Nam, J Kang, HJ Lee, M Lee… - Chemical …, 2018 - ACS Publications
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …

Current developments of coumarin compounds in medicinal chemistry

XM Peng, G LV Damu, C He Zhou - Current pharmaceutical …, 2013 - benthamdirect.com
Coumarin compounds represent an important type of naturally occurring and synthetic
oxygen-containing heterocycles with typical benzopyrone framework. This type of special …

Privileged scaffolds as MAO inhibitors: Retrospect and prospects

AC Tripathi, S Upadhyay, S Paliwal, SK Saraf - European Journal of …, 2018 - Elsevier
This review aims to be a comprehensive, authoritative, critical, and readable review of
general interest to the medicinal chemistry community because it focuses on the …

New frontiers in selective human MAO-B inhibitors: miniperspective

S Carradori, R Silvestri - Journal of medicinal chemistry, 2015 - ACS Publications
Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme
and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline …

A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease

PO Patil, SB Bari, SD Firke, PK Deshmukh… - Bioorganic & medicinal …, 2013 - Elsevier
Monoamine oxidase (MAO) enzyme inhibition is a crucial target for the management of
depression and Alzheimer disease and inhibitors of MAO are the most important drugs for …

Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease

SS **e, X Wang, N Jiang, W Yu, KDG Wang… - European Journal of …, 2015 - Elsevier
A series of novel tacrine-coumarin hybrids were designed, synthesized and evaluated as
multi-target agents against Alzheimer's disease. The biological assays indicated that most of …

Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification

Y Lv, Z Zheng, R Liu, J Guo, C Zhang, Y **e - International Journal of …, 2023 - Elsevier
Monoamine oxidase is a flavin enzyme that catalyzes the oxidation of monoamine
neurotransmitters in the brain. Various toxic by-products, aldehydes and hydrogen peroxide …

Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation

Q He, J Liu, JS Lan, J Ding, Y Sun, Y Fang, N Jiang… - Bioorganic …, 2018 - Elsevier
A series of new coumarin-dithiocarbamate hybrids were designed and synthesized as
multitarget agents for the treatment of Alzheimer's disease. Most of them showed potent and …

Implication of coumarins towards central nervous system disorders

K Skalicka-Woźniak, IE Orhan, GA Cordell… - Pharmacological …, 2016 - Elsevier
Coumarins are widely distributed, plant-derived, 2 H-1-benzopyran-2-one derivatives which
have attracted intense interest in recent years as a result of their diverse and potent …